Sung Hee Oh

Sung Hee Oh

Auto-generated profile, based on publicly available information

Sung Hee Oh

Department of Pediatrics, Hanyang University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2014 in Clinical and Vaccine Immunology
Verified
Journal Article
Closed access
PDF file
SOSung Hee Oh
Sung Hee Oh
ECEun Hwa Choi
Eun Hwa Choi
SSSeon Hee Shin
Seon Hee Shin
YKYun-Kyung Kim
Yun-Kyung Kim
JCJin Keun Chang
Jin Keun Chang
SKShin Ah Kim
Shin Ah Kim
With continuing occurrence of varicella despite increasing vaccine coverage for the past 20 years, a case-based study, a case-control study, and an immunogenicity and safety study were conducted to address the impact of varicella vaccination in South Korea. Varicella patients under the age of 16 years were enrolled for the case-based study. For the case-control study, varicella patients between 12 months and 15 years of age were enrolled with one control matched for each patient. For the immunogenicity and safety study, otherwise healthy children from 12 to 24 months old were immunized with Suduvax (Green Cross, South Korea). Fluorescent antibody to membrane antigen (FAMA) varicella-zoster virus (VZV) antibody was measured before and 6 weeks after immunization. In the case-based study, the median age of the patients was 4 years. Among 152 patients between 1 and 15 years of age, 139 children received varicella vaccine and all had breakthrough infections. Clinical courses were not ameliorated in vaccinated patients, but more vaccinated patients received outpatient rather than inpatient care. In the case-control study, the adjusted overall effectiveness of varicella vaccination was 54%. In the immunogenicity and safety study, the seroconversion rate and geometric mean titer for FAMA antibody were 76.67% and 5.31. Even with increasing varicella vaccine uptake, we illustrate no upward age shift in the peak incidence, a high proportion of breakthrough disease, almost no amelioration in disease presentation by vaccination, and insufficient immunogenicity of domestic varicella vaccine. There is need to improve the varicella vaccine used in South Korea.

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JKJin-Han Kang
Jin-Han Kang
HLHoan Jong Lee
Hoan Jong Lee
YKYun-Kyung Kim
Yun-Kyung Kim
SOSung Hee Oh
Sung Hee Oh
SCSung-Ho Cha
Sung-Ho Cha
EOEsteban Ortiz
Esteban Ortiz
Kang JH, et al. J Korean Med Sci. 2016 Sep;31(9):1383-1391. https://doi.org/10.3346/jkms.2016.31.9.1383

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
ECEun Young Cho
Eun Young Cho
ECEun Young Cho
Eun Young Cho
JKJin-Han Kang
Jin-Han Kang
YKYun-Kyung Kim
Yun-Kyung Kim
DKDong Soo Kim
Dong Soo Kim
HLHoan Jong Lee
Hoan Jong Lee
Cho EY, et al. J Korean Med Sci. 2016 Jul;31(7):1082-1088. https://doi.org/10.3346/jkms.2016.31.7.1082

1 January 2018 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KRKyuyol Rhie
Kyuyol Rhie
ECEun Young Cho
Eun Young Cho
ECEun Young Cho
Eun Young Cho
JLJINA LEE
JINA LEE
JKJin-Han Kang
Jin-Han Kang
HLHoan Jong Lee
Hoan Jong Lee
Rhie K, et al. J Korean Med Sci. 2017 Dec;33(6):e45. https://doi.org/10.3346/jkms.2018.33.e45

10 August 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BKBongyoung Kim
Bongyoung Kim
SMShinje Moon
Shinje Moon
GBGeun-Ryang Bae
Geun-Ryang Bae
HLHyungmin Lee
Hyungmin Lee
HPHyunjoo Pai
Hyunjoo Pai
SOSung Hee Oh
Sung Hee Oh
In 2009, a nationwide sentinel surveillance for hand-foot-mouth disease (HFMD) and herpangina (HA) with neurologic complications was initiated in South Korea. We used this surveillance system to investigate the clinical characteristics of patients with either HFMD or HA with neurologic complications, with the aim of determining risk factors for severe neurologic complications. A retrospective review of medical records was conducted on all cases of HFMD and HA with neurologic complications that were reported in the national system between April 1, 2009 and December 31, 2014. A severe case was defined as having HFMD or HA with encephalitis, polio-like syndrome, or cardiopulmonary failure, and less-severe cases were defined as having HFMD or HA with aseptic meningitis. A total of 138 cases (less-severe: 90/138, 65.2%; severe: 48/138, 24.8%) were included from 28 hospitals; 28 ineligible cases were excluded. Of 48 severe cases, 27 (56.2%) had encephalitis; 14 (29.2%) had polio-like syndrome; and seven (14.6%) had cardiopulmonary syndrome. The median patient age was 36 months (IQR: 18–60) and 63 (45.7%) patients were female. Most patients completely recovered, except for seven cases that were fatal or resulted in long-term symptoms (5.1%, 3 patients with neurologic sequelae and 4 deaths). In a multivariable logistic regression analysis, lethargy (OR = 4.67, 95% CI: 1.37–15.96, P = 0.014), female sex (OR = 3.51, 95% CI: 1.17–10.50, P = 0.025), and enterovirus A71 (OR = 3.55, 95% CI: 1.09–11.57, P = 0.035) were significantly associated with severe neurologic complications in HFMD and HA patients. In patients with HFMD and HA, lethargy, female, and enterovirus A71 may predict severe neurologic complications.

1 January 2012 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JKJeong Hee Ko
Jeong Hee Ko
JKJi Hye Kim
Ji Hye Kim
JKJin Han Kang
Jin Han Kang
JKJong-Hyun Kim
Jong-Hyun Kim
BEByungwook Eun
Byungwook Eun
SOSung Hee Oh
Sung Hee Oh
Ko JH, et al. J Korean Med Sci. 2012 Apr;27(4):408-415. http://dx.doi.org/10.3346/jkms.2012.27.4.408